Similar Posts
Theriva™ Biologics anuncia la designación de vía rápida concedida por la FDA estadounidense al VCN-01 para el tratamiento del cáncer de páncreas metastásico – Bio Tech Winners
May 24, 2024 by Leave a Comment Last Updated on May 24, 2024 by [#item_full_content] Like this: Like Loading… Related Filed Under: biotech news, News Reader Interactions This site uses Akismet to reduce spam. Learn how your comment data is processed. Source link
2 Rising Dividend Stocks That Should Benefit From Rate Cuts
Image source: Getty Images Market sentiment on dividend stocks started to shift last fall from selling on fears of higher interest rates to bargain hunting based on anticipation of rate cuts in 2024. The Bank of Canada has already reduced interest rates twice, and more cuts are expected. The U.S. Federal Reserve could start cutting…
SNT – Syntara Limited
Fallen from $4.5 to $2.2 in the last six months?? Whats the go? Bit disappointing, haven’t seen it around these levels for around a year and a half. The broker firms are still giving it buying recommendations which can be seen on the company’s website. Thoughts? I really like this stock. I think the reason…
Ericsson Falls Short of Estimates as Sales in India Struggle – Equitypandit
January 24, 2025January 24, 2025 Ericsson AB’s earnings missed analysts’ expectations in the fourth quarter, as sales to India did not recover as anticipated. Ericsson’s adjusted earnings for Q4 were 9.8 billion Swedish kronor ($894 million), up 33% from last year, but missed analysts’ estimate of 10.3 billion kronor….
$RDDT Issues First Weekly MVB Buy Signal
By Lawrence G. McMillan $RDDT issued its first weekly McMillan Volatility Band (MVB) Buy signal (chart above) this week since being listed—an encouraging development for bullish traders watching the stock’s momentum. On the daily chart (below), $RDDT broke out above the key resistance area near 130, successfully retested that breakout level, and has since resumed…
Recession-Proof Your Portfolio With Top Stocks to Buy Now
Amid economic headlines of slowing growth and persistent inflationary pressures, navigating the financial markets can feel like steering through turbulent waters. According to Commerce Department estimates, U.S. Gross Domestic Product (GDP) slowed to an annual rate of 1.3% in the first quarter of 2024, decelerating from a brisk 3.4% growth rate observed in late 2023….
